Literature DB >> 33542555

Progressive gammopathy and coagulopathy in a young English bulldog.

Jennifer L Grady1, Anne Avery1, A Russell Moore1, Lauren J Harris1, Neketa Kakar1, Emily D Rout1.   

Abstract

A restricted polyclonal or biclonal gammopathy resulting in bleeding tendencies was diagnosed in a young, neutered male English bulldog with concurrent splenomegaly, anemia, and severe elevations in IgM and, to a lesser degree, IgA immunoglobulins. There was a positive clinical response to treatment with prednisone and chlorambucil. This case bears similarity to a recently published syndrome of polyclonal gammopathy that is not neoplastic in origin in this breed. Key clinical message: The current case describes the management and clinical course of a recently described syndrome of polyclonal gammopathy in English bulldogs. Copyright and/or publishing rights held by the Canadian Veterinary Medical Association.

Entities:  

Mesh:

Year:  2021        PMID: 33542555      PMCID: PMC7808204     

Source DB:  PubMed          Journal:  Can Vet J        ISSN: 0008-5286            Impact factor:   1.008


  27 in total

1.  Effect of chemotherapy schedule on response in Waldenström's macroglobulinemia in a dog.

Authors:  C B Greenberg; P A Boria; R E Raskin; M D Lucroy
Journal:  J Vet Intern Med       Date:  2008 Jan-Feb       Impact factor: 3.333

2.  Waldenström's macroglobulinemia in a dog with a bleeding diathesis.

Authors:  Laetitia Jaillardon; Corinne Fournel-Fleury
Journal:  Vet Clin Pathol       Date:  2011-08-09       Impact factor: 1.180

3.  Pseudo-monoclonal gammopathy: a report of four cases.

Authors:  Majd D Jawad; Ronald S Go; Thomas E Witzig; Joseph R Mikhael; Aishwarya Ravindran; David L Murrray
Journal:  Haematologica       Date:  2017-08-03       Impact factor: 9.941

4.  Clinicopathologic features of lingual canine T-zone lymphoma.

Authors:  L J Harris; E D Rout; K L Hughes; J D Labadie; B Boostrom; J A Yoshimoto; C M Cannon; P R Avery; E J Ehrhart; A C Avery
Journal:  Vet Comp Oncol       Date:  2017-07-27       Impact factor: 2.613

5.  Identification of canine IgG and its subclasses, IgG1, IgG2, IgG3 and IgG4, by immunofixation and commercially available antisera.

Authors:  Dillon Donaghy; A Russell Moore
Journal:  Vet Immunol Immunopathol       Date:  2020-01-23       Impact factor: 2.046

6.  Multiple myeloma in a dog with multiple concurrent infectious diseases and persistent polyclonal gammopathy.

Authors:  Caroline Geigy; Barbara Riond; Carla Rohrer Bley; Paula Grest; Patrick Kircher; Hans Lutz
Journal:  Vet Clin Pathol       Date:  2012-12-31       Impact factor: 1.180

Review 7.  Protein characterization using electrophoresis and immunofixation; a case-based review of dogs and cats.

Authors:  A Russell Moore; Paul R Avery
Journal:  Vet Clin Pathol       Date:  2019-07-03       Impact factor: 1.180

Review 8.  Systemic manifestations of monoclonal gammopathy.

Authors:  Olivier Decaux; Elisabeth Laurat; Antoinette Perlat; Claire Cazalets; Patrick Jego; Bernard Grosbois
Journal:  Eur J Intern Med       Date:  2009-02-04       Impact factor: 4.487

9.  Histopathological and molecular features of persistent polyclonal B-cell lymphocytosis (PPBL) with progressive splenomegaly.

Authors:  Ilaria Del Giudice; Stefano A Pileri; Maura Rossi; Elena Sabattini; Cristina Campidelli; Irene Della Starza; Maria S De Propris; Francesca Mancini; Maria P Perrone; Paola Gesuiti; Daniele Armiento; Luisa Quattrocchi; Agostino Tafuri; Angela Amendola; Francesca R Mauro; Anna Guarini; Robin Foà
Journal:  Br J Haematol       Date:  2008-12-26       Impact factor: 6.998

10.  Hyper IgM Syndrome: a Report from the USIDNET Registry.

Authors:  Emily A Leven; Patrick Maffucci; Hans D Ochs; Paul R Scholl; Rebecca H Buckley; Ramsay L Fuleihan; Raif S Geha; Coleen K Cunningham; Francisco A Bonilla; Mary Ellen Conley; Ronald M Ferdman; Vivian Hernandez-Trujillo; Jennifer M Puck; Kathleen Sullivan; Elizabeth A Secord; Manish Ramesh; Charlotte Cunningham-Rundles
Journal:  J Clin Immunol       Date:  2016-05-17       Impact factor: 8.542

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.